We are live on ! Find out more
NEO icon

NeoGenomics

259 hedge funds and large institutions have $1.74B invested in NeoGenomics in 2024 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 70 increasing their positions, 93 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

273% more call options, than puts

Call options by funds: $10.2M | Put options by funds: $2.74M

0% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 32

2% less funds holding

Funds holding: 263259 (-4)

2.35% less ownership

Funds ownership: 100.76%98.42% (-2.3%)

14% less capital invested

Capital invested by funds: $2.02B → $1.74B (-$278M)

25% less repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 93

40% less funds holding in top 10

Funds holding in top 10: 53 (-2)

Holders
259
Holders Change
-4
Holders Change %
-1.52%
% of All Funds
3.74%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.04%
New
32
Increased
70
Reduced
93
Closed
32
Calls
$10.2M
Puts
$2.74M
Net Calls
+$7.49M
Net Calls Change
-$10.1M
Name Holding Trade Value Shares
Change
Change in
Stake
SBH
26
Segall Bryant & Hamill
Illinois
$15.7M -$2.81M -198,098 -15%
Charles Schwab
27
Charles Schwab
California
$14.9M -$12K -843 -0.1%
Point72 Asset Management
28
Point72 Asset Management
Connecticut
$14.3M -$16.5M -1,165,943 -53%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$13.2M +$227K +16,023 +2%
KFO
30
Kopp Family Office
Minnesota
$13.1M +$713K +50,266 +6%
OAM
31
Oberweis Asset Management
Illinois
$9.27M -$971K -68,500 -9%
Principal Financial Group
32
Principal Financial Group
Iowa
$8.74M -$449K -31,665 -5%
UBS AM
33
UBS AM
Illinois
$8.69M +$2.91M +205,436 +49%
RA
34
Royce & Associates
New York
$8.6M +$635K +44,799 +8%
Norges Bank
35
Norges Bank
Norway
$8.41M -$4.61M -325,276 -35%
T. Rowe Price Associates
36
T. Rowe Price Associates
Maryland
$8.16M -$807K -56,898 -9%
Ameriprise
37
Ameriprise
Minnesota
$6.78M -$732K -51,654 -10%
CS
38
Candriam SCA
Luxembourg
$6.75M +$1.59M +112,009 +30%
Invesco
39
Invesco
Georgia
$6.67M -$510K -35,984 -7%
N
40
Nuveen
North Carolina
$6.14M -$2.52M -177,521 -29%
William Blair & Company
41
William Blair & Company
Illinois
$5.68M -$903K -63,688 -13%
RhumbLine Advisers
42
RhumbLine Advisers
Massachusetts
$5.3M -$46.7K -3,297 -0.9%
Legal & General Group
43
Legal & General Group
United Kingdom
$4.94M -$4.11K -290 -0.1%
Jane Street
44
Jane Street
New York
$4.83M +$1.14M +80,727 +30%
NCGI
45
Next Century Growth Investors
Minnesota
$4.07M -$493K -34,775 -11%
Public Sector Pension Investment Board (PSP Investments)
46
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$3.9M +$279K +19,712 +8%
Allianz Asset Management
47
Allianz Asset Management
Germany
$3.89M +$2.55K +180 +0.1%
SEI Investments
48
SEI Investments
Pennsylvania
$3.66M +$2.26M +159,350 +153%
Swiss National Bank
49
Swiss National Bank
Switzerland
$3.49M
GKIM
50
GW&K Investment Management
Massachusetts
$3.01M -$152K -10,745 -5%

NEO Hedge Fund Activity: Q2 2024 in Review

259 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in NeoGenomics (NEO) for Q2 2024, worth a combined $1.74B — down 14% from $2.02B a quarter earlier.

Fund positioning in NEO was balanced in Q2 2024: 32 funds opened new positions, 32 closed out, 70 added to existing stakes and 93 trimmed.

The largest buyer was Schroder Investment Management Group, adding an estimated $15.5M. The largest seller was Point72 Asset Management, cutting an estimated $16.5M.

  • 259 institutional investors held NeoGenomics (NEO) as of Q2 2024, down from 263 in Q1 2024.
  • Funds reported $1.74B of NeoGenomics stock for Q2 2024, down 14% quarter-over-quarter.
  • 32 funds opened new NeoGenomics positions in Q2 2024 and 32 closed out, a net change of 0 holders.
  • The largest NeoGenomics buyer in Q2 2024 was Schroder Investment Management Group, an estimated $15.5M added.
  • The largest NeoGenomics seller in Q2 2024 was Point72 Asset Management, an estimated $16.5M sold.

Based on aggregated 13F filings for Q2 2024.